Statera Biopharma Inc Sustainability Reports
A clinical-stage biopharmaceutical company developing novel immunotherapies designed to rebalance the body's immune system and restore homeostasis. The therapies target autoimmune diseases, neutropenia, anemia, emerging viruses, and cancers.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 5493000BKEMABEVWAK70
FIGI: BBG001SL8TJ8
1 reports from 2021 to 2021
